A novel anti-atherosclerotic mechanism of quercetin: Competitive binding to KEAP1 via Arg483 to inhibit macrophage pyroptosis-Reference-Cited by-同舟云学术

A novel anti-atherosclerotic mechanism of quercetin: Competitive binding to KEAP1 via Arg483 to inhibit macrophage pyroptosis

Published:2022-11 Issue: Volume:57 Page:102511
ISSN:2213-2317
Container-title:Redox Biology
language:en
Short-container-title:Redox Biology

Author:

Luo Xing,Weng Xiuzhu,Bao Xiaoyi,Bai Xiaoxuan,Lv Ying,Zhang Shan,Chen Yuwu,Zhao Chen,Zeng Ming,Huang Jianxin,Xu Biyi,Johnson Thomas W.,White Stephen J.,Li Ji,Jia Haibo,Yu Bo

Publisher

Elsevier BV

Subject

Organic Chemistry,Biochemistry,Clinical Biochemistry

Reference51 articles.

1. Atherosclerosis;Libby;Nat. Rev. Dis. Prim.,2019

2. Calcium deposition within coronary atherosclerotic lesion: implications for plaque stability;Jinnouchi;Atherosclerosis,2020

3. Macrophage phenotype and function in different stages of atherosclerosis;Tabas;Circ. Res.,2016

4. Granzyme A from cytotoxic lymphocytes cleaves GSDMB to trigger pyroptosis in target cells;Zhou;Science (New York, NY),2020

5. Structural mechanism for GSDMD targeting by autoprocessed caspases in pyroptosis;Wang;Cell,2020

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Salinomycin, a potent inhibitor of XOD and URAT1, ameliorates hyperuricemic nephropathy by activating NRF2, modulating the gut microbiota, and promoting SCFA production;Chemico-Biological Interactions;2024-11

2. Artemisinin inhibits neuronal ferroptosis in Alzheimer’s disease models by targeting KEAP1;Acta Pharmacologica Sinica;2024-09-09

3. Quercetin ameliorates atherosclerosis by inhibiting inflammation of vascular endothelial cells via Piezo1 channels;Phytomedicine;2024-09

4. Life cycle of macrophages in atherosclerotic inflammation progression and resolution: mediators and interventions (narrative review);Emergency and Critical Care Medicine;2024-08-06

5. Sweroside alleviates pressure overload-induced heart failure through targeting CaMKⅡδ to inhibit ROS-mediated NF-κB/NLRP3 in cardiomyocytes;Redox Biology;2024-08